No Data
No Data
IX Biopharma Restructures Board Committees for Efficiency
IX Biopharma Welcomes Aging Expert to Advisory Board
IX Biopharma Schedules Extraordinary General Meeting for Scheme Extensions
Financial Statements and Related Announcement-Auditor's Comments of Accounts
IX Biopharma Advances Wafermine Out-Licensing, Starts Preclinical Trials for IXB 401
New Study Demonstrates That SL-NAD+ Delivers NAD+ Into Cells
No Data
No Data
hh488 : They trying to release some positive news prior to the payment of the rights. So don't get caught & jump in right away!